Request Discount

Gastrointestinal Drugs Market (Drug Category - Acid Neutralizers, Laxatives and Anti-diarrheal, Antiemetic and Antinauseants, Anti-inflammatory, Biologics, and Others; Route of Administration - Oral, Parenteral, and Rectal; Disease Type - Gastroesophageal Reflux Disorder, Irritable Bowel Syndrome, and Others; End User - Hospital Pharmacies, Retail Pharmacies, and Others): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025

  • Published : April, 2019

  • Rep Id : HC0470

  • Category : Healthcare & Medical Devices

  • Status : Published

This report provides exclusive insights into the COVID-19 impact on the Gastrointestinal Drugs Market. The detailed analysis provides information about the impact of the outbreak on the demand and supply conditions, trends and forecasts of the Gastrointestinal Drugs Market. Moreover, the impact analysis covers the study of the COVID-19 on the supply chain of Gastrointestinal Drugs Market. The sectoral impact shall provide insights into both short term and long term effects of the pandemic on the related and support industries.

A recent report published by Infinium Global Research on gastrointestinal drugs market provides in-depth analysis of segments and sub-segments in the global as well as regional gastrointestinal drugs market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional gastrointestinal drugs market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global gastrointestinal drugs market. According to the report, the global gastrointestinal drugs market is projected to grow at a CAGR of 4.9% over the forecast period of 2019-2025.

Global Gastrointestinal Drugs Market


Segment Covered

The report on global gastrointestinal drugs market covers segments such as drug category, route of administration, disease type, and end user. On the basis of drug category, the sub-markets include acid neutralizers, laxatives and anti-diarrheal, antiemetic and antinauseants, anti-inflammatory, biologics, and others. On the basis of route of administration, the sub-markets include oral, parenteral, and rectal. On the basis of disease type, the sub-markets include gastroesophageal reflux disorder, irritable bowel syndrome, and others. On the basis of end user, the sub-markets include hospital pharmacies, retail pharmacies, and others.


Companies Profiled:

The report provides profiles of the companies in the market such as Allergan Plc., Abbott Laboratories, Bayer AG, AstraZeneca plc, GlaxoSmithKline Plc., Boehringer Ingelheim GmbH., Sanofi S.A.Johnson & Johnson, and Bausch Health Companies Inc.


Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of gastrointestinal drugs market. Moreover, the study highlights current market trends and provides forecast from 2019-2025. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.

Other Reports in This Category
24 hour delivery through email
9923950043 Monday to Frieday 9am-7pm
looking for discount